SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-481950
Filing Date
2016-02-26
Accepted
2016-02-26 16:13:03
Documents
90
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d116816d10k.htm 10-K 981189
2 EX-21.1 d116816dex211.htm EX-21.1 3913
3 EX-23.1 d116816dex231.htm EX-23.1 4991
4 EX-31.1 d116816dex311.htm EX-31.1 8994
5 EX-31.2 d116816dex312.htm EX-31.2 8960
6 EX-32.1 d116816dex321.htm EX-32.1 3542
7 EX-32.2 d116816dex322.htm EX-32.2 3548
14 GRAPHIC g116816g04h88.jpg GRAPHIC 109665
  Complete submission text file 0001193125-16-481950.txt   6423267

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT kerx-20151231.xml EX-101.INS 1133683
9 XBRL TAXONOMY EXTENSION SCHEMA kerx-20151231.xsd EX-101.SCH 64635
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kerx-20151231_cal.xml EX-101.CAL 90422
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kerx-20151231_def.xml EX-101.DEF 423116
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE kerx-20151231_lab.xml EX-101.LAB 552849
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kerx-20151231_pre.xml EX-101.PRE 498152
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30929 | Film No.: 161461974
SIC: 2834 Pharmaceutical Preparations